Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Oosterwijk

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
Proven non-carriers in BRCA families have an earlier age of onset of breast cancerJanet R Vos, Geertruida H de Bock, Natalia Teixeira, et al.
Maturitas|August 5, 2015
Ovarian cancer in BRCA1/2 mutation carriers: The impact of mutation position and family history on the cancer riskNatalia Teixeira, Marian J E Mourits, Janet R Vos, et al.
Maturitas|June 17, 2017
Predictability of BRCA1/2 mutation status in patients with ovarian cancer: How to select women for genetic testing in middle-income countriesNatalia Teixeira, Simone Maistro, Maria Del Pilar Estevez Diz, et al.
BMC Medical Informatics and Decision Making|May 1, 2013
The effectiveness of a graphical presentation in addition to a frequency format in the context of familial breast cancer risk communication: a multicenter controlled trialLidewij Henneman, Jan C Oosterwijk, Christi J van Asperen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2009
The validation of a simulation model incorporating radiation risk for mammography breast cancer screening in women with a hereditary-increased breast cancer riskMarcel J W Greuter, Marijke C Jansen-van der Weide, Cathrien E Jacobi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation CarriersJanet R Vos, Li Hsu, Richard M Brohet, et al.
Maturitas|January 21, 2015
Stopping ovarian cancer screening in BRCA1/2 mutation carriers: effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimensCatheleine M G van Driel, Geertruida H de Bock, Henriette J G Arts, et al.
Psycho-Oncology|November 13, 2010
Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-resultJoël Vos, Encarna Gómez-García, Jan C Oosterwijk, et al.
Familial Cancer|June 9, 2018
Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomyNatalia Teixeira, Marian J Mourits, Jan C Oosterwijk, et al.
Patient Education and Counseling|June 21, 2011
Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does notJoël Vos, Jan C Oosterwijk, Encarna Gomez-Garcia, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
Proven non-carriers in BRCA families have an earlier age of onset of breast cancerJanet R Vos, Geertruida H de Bock, Natalia Teixeira, et al.
Maturitas|August 5, 2015
Ovarian cancer in BRCA1/2 mutation carriers: The impact of mutation position and family history on the cancer riskNatalia Teixeira, Marian J E Mourits, Janet R Vos, et al.
Maturitas|June 17, 2017
Predictability of BRCA1/2 mutation status in patients with ovarian cancer: How to select women for genetic testing in middle-income countriesNatalia Teixeira, Simone Maistro, Maria Del Pilar Estevez Diz, et al.
BMC Medical Informatics and Decision Making|May 1, 2013
The effectiveness of a graphical presentation in addition to a frequency format in the context of familial breast cancer risk communication: a multicenter controlled trialLidewij Henneman, Jan C Oosterwijk, Christi J van Asperen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2009
The validation of a simulation model incorporating radiation risk for mammography breast cancer screening in women with a hereditary-increased breast cancer riskMarcel J W Greuter, Marijke C Jansen-van der Weide, Cathrien E Jacobi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation CarriersJanet R Vos, Li Hsu, Richard M Brohet, et al.
Maturitas|January 21, 2015
Stopping ovarian cancer screening in BRCA1/2 mutation carriers: effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimensCatheleine M G van Driel, Geertruida H de Bock, Henriette J G Arts, et al.
Psycho-Oncology|November 13, 2010
Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-resultJoël Vos, Encarna Gómez-García, Jan C Oosterwijk, et al.
Familial Cancer|June 9, 2018
Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomyNatalia Teixeira, Marian J Mourits, Jan C Oosterwijk, et al.
Patient Education and Counseling|June 21, 2011
Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does notJoël Vos, Jan C Oosterwijk, Encarna Gomez-Garcia, et al.
Pageof 10